期刊文献+

紫杉醇联合顺铂、氟尿嘧啶治疗晚期上消化道癌43例临床分析 被引量:4

暂未订购
导出
摘要 目的:观察紫杉醇联合顺铂、氟尿嘧啶(TDF方案)治疗晚期上消化道癌的疗效及其不良反应。方法:对食管癌24例,胃癌19例,应用TDF方案化疗,即紫杉醇135mg/m2,静脉滴注d1;顺铂20mg,静脉滴注,d1~d5;氟尿嘧啶500mg,静脉滴注,d1~d5;28天为一个周期。2周期后按WHO标准进行评价。结果:43例可评价疗效,其中完全缓解4例,部分缓解11例,无变化11例,进展17例,客观有效率为35%。中位生存期6.5个月。主要不良反应为骨髓抑制。结论:TDF方案治疗晚期上消化道癌的近期疗效肯定,不良反应轻微,患者耐受性较好。
出处 《蚌埠医学院学报》 CAS 2007年第4期451-452,共2页 Journal of Bengbu Medical College
  • 相关文献

参考文献10

二级参考文献47

  • 1卢凯华,黄普文,张锦英,仇金荣,刘连科,朱陵君.乐沙锭联合亚叶酸钙及氟脲嘧啶治疗晚期胃癌22例报告[J].南京医科大学学报(自然科学版),2004,24(5):517-518. 被引量:4
  • 2施为建,季国忠,王继荣,许宏岳.恶性肿瘤患者血清TSGF检测的临床意义[J].中国误诊学杂志,2004,4(7):1058-1059. 被引量:6
  • 3汪竹,刘晓丹,童建东.泰索帝联合顺铂和5-氟脲嘧啶治疗晚期胃癌的疗效观察[J].药学进展,2002,26(1):36-39. 被引量:11
  • 4Lokich JJ. Combined pachitaxel, cisplatin and etoposide for patients with pr eviously untreated esophageal and gastro esophageal carcinomas [J].Cancer 1999,85 ( 11 ): 2347 - 2351.
  • 5Klauber N, Parangi S, Flynn E, et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-Me-thoxyestradiol and paclitaxel[J]. Cancer Res, 1997, 57(1 ) :81.
  • 6Ajani JA. Treatment of patients with upper gastrointestinal carcinoma[J]. Seruim Oncol, 1997, 24(6 suppl 19):1972.
  • 7Tamura F, Ohtsu A, Boku N, et al. Three-hour infusion of paclitaxel for advanced gastric cancer [ J ]. Proc Annu Meet Am Soc Clin Oncol, 1997, 16(A):1091.
  • 8Petrasch S, Welt A, Reinacher A, et al. Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic cesophageal cancer[ J ]. Br J Cancer, 1998, 78 (4) :511 -517.
  • 9Perez EA, Vogel CL, Irwin DH, et al. Multicenter phase II trial of weekly pac]itaxel in women with metastatic breast cancer[J]. J Clin Oncol, 2001, 19(22) :4216 -4221.
  • 10Roth AD, Ajani J. Docetaxel-based chemotherapy in the treatment of gastric cancer. Ann Oncol, 2003,14 (Suppl 2) : 1141-1144.

共引文献82

同被引文献19

  • 1De-Sheng XIAO Ji-Fang WEN Jing-He LI Kuan-Song WANG Zhong-Liang HU Jian-Hua ZHOU Zheng-Hao DENG Ying LIU.Effect of DPC4 Gene on Invasion and Metastasis of Colorectal Carcinoma Cells[J].Acta Biochimica et Biophysica Sinica,2006,38(12):883-892. 被引量:8
  • 2中国肿瘤防治研究办公室卫生部统计信息中心.中国试点市、县恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002.28-34.
  • 3Ajani J A, Ilson D H, Pangherty K, et al. Activity of taxol in patients with squamous cell carcinoma and adenocarcinorna of the esophagus[J]. J Natl Cancer Inst, 1994, 86: 1086.
  • 4Ilson D H, Ajani J, Bhalla K, et al. Phase Ⅱ trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus[J]. J Clin Oncol, 1998, 16(5): 1826.
  • 5Strieth S, Eichhom M E, Sauer B, et al. Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature[J]. Int J Cancer, 2004, 110(1): 117.
  • 6Schmitt-Sody M, Strlech S, Krasnid S, et al. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy [J]. Clin Cancer Res, 2003, 9(6): 2335.
  • 7Ajani JA, Ilson DH, Daugherty K, et al. Paclitaxel in the treatment of carcinoma of the esophagus [J]. Semin Oncol, 1995, 22(Suppl 6): 35-40.
  • 8Ilson DH, Ajani J, Bhalla K, ct al. Phase Ⅱ trial ofpacli taxel,fluomuracil,and cisplat in in patients with advanced carcinoma of the esophagus [J]. J Clin Oncol, 1998, 16(5): 1826-1834.
  • 9Papp A, Cseke L, Pavlovics G, et al. The effect of preoperative ehemo-radiotherapy in the treatment of locally advanced squamous cell carcinoma in the upperand middlethirds of the esophagus [J]. MagySeb, 2007, 60(3): 123-129.
  • 10Jemal A, Center MM, Desantis C, et al. Global patterns of cancer inci- dence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 2010,19 : 1893-1907.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部